MHRA takes over chair of the International Access Consortium for 2026

27th January 2026

Summary: The MHRA has formally taken the lead role as Chair of the Access Consortium for 2026, a coalition of like-minded regulators including Australia’s Therapeutic Goods Administration, Health Canada, Singapore’s Health Sciences Authority and Swissmedic. This marks a new phase of international cooperation focused on harmonising regulatory requirements, sharing expertise and expanding work-sharing initiatives to reduce duplication and accelerate access to high-quality, safe and effective medicines for patients across member countries. The consortium’s collaborative framework supports streamlined scientific assessments and coordinated regulatory approaches, helping regulators and industry work together more efficiently on global health challenges.

Link: https://www.gov.uk/government/news/mhra-takes-over-chair-of-international-access-consortium-for-2026

Back to Recent News